LESLEY OTT: Open Payments
NPI 1124603154 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 74 payments from 20 companies in 2025. Trend: 2023 $774 · 2024 $735 · 2025 $1,470
Food & beverage: $1,271Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $262 |
| ABBVIE INC. | 10 | $213 |
| Galderma Laboratories, L.P. | 20 | $185 |
| E.R. Squibb & Sons, L.L.C. | 1 | $100 |
| Organon LLC | 5 | $97 |
| LEO Pharma Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $63 |
| UCB, Inc. | 2 | $58 |
| Amgen Inc. | 3 | $58 |
| PFIZER INC. | 3 | $52 |
Products named: TREMFYA, SKYRIZI, AKLIEF, DUPIXENT, Sotyktu, Bimzelx, OTEZLA, CIBINQO.
Industry payments across LA — which companies pay providers there.
